Joel Greenblatt's RMD Position Overview
Joel Greenblatt (via Gotham Asset Management, LLC) currently holds 50.7K shares of ResMed Inc. (RMD) worth $13.88 M, representing 0.06% of the portfolio. First purchased in 2013-Q2, this long-term strategic position has been held for 50 quarters.
Based on 13F filings since 2013, Joel Greenblatt has maintained a long-term strategic position in RMD, representing a significant commitment to this investment thesis. Largest addition occurred in Q1 2014, adding 295.1K shares. Largest reduction occurred in Q2 2014, reducing 511.7K shares.
Analysis based on 13F filings available since 2013 Q2
Joel Greenblatt's ResMed (RMD) Holding Value Over Time
Track share changes against reported price movement
Quarterly ResMed (RMD) Trades by Joel Greenblatt
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2013 | +56,318 | Add 0.00% | 56,317 | $45.14 |
| Q3 2013 | -31,125 | Reduce 55.27% | 25,192 | $52.83 |
| Q4 2013 | +209,695 | Add 832.39% | 234,887 | $47.08 |
| Q1 2014 | +295,129 | Add 125.65% | 530,016 | $44.69 |
| Q2 2014 | -511,695 | Reduce 96.54% | 18,321 | $50.65 |
| Q3 2014 | -18,321 | Sold Out | 18,321 | $0.00 |
| Q3 2015 | +4,210 | New Buy | 4,210 | $51.07 |
| Q4 2015 | -4,210 | Sold Out | 4,210 | $0.00 |
| Q1 2016 | +112,449 | New Buy | 112,449 | $57.82 |
| Q2 2016 | +150,509 | Add 133.85% | 262,958 | $63.23 |
| Q3 2016 | +33,425 | Add 12.71% | 296,383 | $64.79 |
| Q4 2016 | -283,450 | Reduce 95.64% | 12,933 | $62.01 |
| Q1 2017 | -3,218 | Reduce 24.88% | 9,715 | $71.95 |
| Q2 2017 | -9,715 | Sold Out | 9,715 | $0.00 |
| Q4 2017 | +4,751 | New Buy | 4,751 | $84.61 |
| Q1 2018 | -4,751 | Sold Out | 4,751 | $0.00 |
| Q2 2018 | +74,711 | New Buy | 74,711 | $103.59 |
| Q3 2018 | +101,291 | Add 135.58% | 176,002 | $115.34 |
| Q4 2018 | -114,490 | Reduce 65.05% | 61,512 | $113.86 |
| Q1 2019 | -55,711 | Reduce 90.57% | 5,801 | $103.95 |
| Q2 2019 | -5,801 | Sold Out | 5,801 | $0.00 |
| Q3 2019 | +4,459 | New Buy | 4,459 | $135.01 |
| Q4 2019 | -4,459 | Sold Out | 4,459 | $0.00 |
| Q1 2020 | +4,160 | New Buy | 4,160 | $147.36 |
| Q2 2020 | -3,049 | Reduce 73.29% | 1,111 | $191.72 |
| Q3 2020 | +32,153 | Add 2894.06% | 33,264 | $171.42 |
| Q4 2020 | -20,408 | Reduce 61.35% | 12,856 | $212.59 |
| Q1 2021 | -12,856 | Sold Out | 12,856 | $0.00 |
| Q4 2021 | +6,562 | New Buy | 6,562 | $260.44 |
| Q1 2022 | -5,473 | Reduce 83.40% | 1,089 | $242.42 |
| Q2 2022 | -44 | Reduce 4.04% | 1,045 | $209.57 |
| Q3 2022 | -52 | Reduce 4.98% | 993 | $218.53 |
| Q4 2022 | +12 | Add 1.21% | 1,005 | $208.13 |
| Q1 2023 | -1,005 | Sold Out | 1,005 | $0.00 |
| Q2 2023 | +3,579 | New Buy | 3,579 | $218.50 |
| Q3 2023 | +10,196 | Add 284.88% | 13,775 | $147.87 |
| Q4 2023 | -2,396 | Reduce 17.39% | 11,379 | $172.02 |
| Q1 2024 | +13,971 | Add 122.78% | 25,350 | $198.03 |
| Q2 2024 | +18,851 | Add 74.36% | 44,201 | $191.42 |
| Q3 2024 | +2,242 | Add 5.07% | 46,443 | $244.12 |
| Q4 2024 | -20,563 | Reduce 44.28% | 25,880 | $228.69 |
| Q1 2025 | -6,935 | Reduce 26.80% | 18,945 | $223.85 |
| Q2 2025 | -7,275 | Reduce 38.40% | 11,670 | $258.00 |
| Q3 2025 | +39,035 | Add 334.49% | 50,705 | $273.73 |
Joel Greenblatt's ResMed Investment FAQs
Joel Greenblatt first purchased ResMed Inc. (RMD) in Q2 2013, acquiring 56,317 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Joel Greenblatt has held ResMed Inc. (RMD) for 50 quarters since Q2 2013. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Joel Greenblatt's largest addition to ResMed Inc. (RMD) was in Q1 2014, adding 530,016 shares worth $23.69 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Joel Greenblatt's firm, Gotham Asset Management, LLC, owns 50,705 shares of ResMed Inc. (RMD), valued at approximately $13.88 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, ResMed Inc. (RMD) represents approximately 0.06% of Joel Greenblatt's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Joel Greenblatt's peak holding in ResMed Inc. (RMD) was 530,016 shares, as reported at the end of Q1 2014. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.